News
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
49m
Smithsonian Magazine on MSNTexas Will Invest $50 Million in Ibogaine Research, Testing the Psychedelic Drug’s Medical PotentialThe state's new law marks one of the largest government investments into psychedelics to date, with advocates citing the drug ...
31m
Asianet Newsable on MSNUS Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding PharmaciesThe judge said that the FDA had appropriately weighed supply and demand data for the drugs and properly removed them from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results